Bide Pharmatech Co., Ltd.

XSSC:688073 Stock Report

Market Cap: CN¥5.3b

Bide Pharmatech Management

Management criteria checks 0/4

We currently do not have sufficient information about the CEO.

Key information

Lan Dai

Chief executive officer

CN¥2.5m

Total compensation

CEO salary percentagen/a
CEO tenure2.5yrs
CEO ownership34.3%
Management average tenureno data
Board average tenure2.5yrs

Recent management updates

Recent updates

CEO

Lan Dai (53 yo)

2.5yrs
Tenure
CN¥2,510,000
Compensation

Ms. Lan Dai is GM & Chairman of Bide Pharmatech Co. Ltd. from October 13, 2023, Director from October 17, 2020 and serves as its Secretary of the Board of Directors.

Board Members

NamePositionTenureCompensationOwnership
Lan Dai
GM, Chairman & Secretary of the Board5.5yrsCN¥2.51m34.26%
CN¥ 1.8b
Yun Zhao
Assistant to GM & Director2.5yrsCN¥1.64mno data
Mei Cai
Chairman of the Supervisory Board & QA Manager5.5yrsno datano data
Jiangbo Wan
Brand Senior Director & Supervisor2.5yrsCN¥712.60kno data
Ronghao Li
R&D Director and Supervisor5.5yrsCN¥549.90kno data
Yongping Tao
Independent Director2.5yrsCN¥90.00kno data
Zhichang Liu
Independent Director2.5yrsCN¥90.00kno data
Jian Li
Independent Director1.8yrsCN¥52.50kno data
2.5yrs
Average Tenure
44yo
Average Age

Experienced Board: 688073's board of directors are not considered experienced ( 2.5 years average tenure), which suggests a new board.

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2026/04/20 19:16
End of Day Share Price 2026/04/20 00:00
Earnings2025/12/31
Annual Earnings2025/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Bide Pharmatech Co., Ltd. is covered by 4 analysts. 2 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Kai WangCitic Securities Co., Ltd.
Xiao Wei LinEverbright Securities Co. Ltd.
Yuan Yuan SunIndustrial Securities Co. Ltd.